Suppr超能文献

带金属颗粒的Polyflex支架在中央气道肿瘤性梗阻患者中的应用。

Use of studded Polyflex stents in patients with neoplastic obstructions of the central airways.

作者信息

Bolliger Chris T, Breitenbuecher Albrecht, Brutsche Martin, Heitz Markus, Stanzel Franz

机构信息

Lung Unit, Department of Internal Medicine, University of Stellenbosch, Tygerberg, Cape Town, South Africa.

出版信息

Respiration. 2004 Jan-Feb;71(1):83-7. doi: 10.1159/000075654.

Abstract

BACKGROUND

The Polyflex is a commercially available silastic airway stent with proven efficacy. Due to a smooth outer surface its anchorage in the airway wall is superficial which may lead to stent migration.

OBJECTIVE

To study the performance of an newer version of the Polyflex stent with a studded outer surface, which should improve anchorage.

METHODS

In a 5-centre international study the new stent was prospectively tested in symptomatic patients with neoplastic central airway stenosis of more that 50% of normal diameter. Insertion technique, efficacy of stent placement and stent-related complications were recorded before, 1 month and 3 months post stent placement.

RESULTS

Under general anaesthesia and rigid bronchoscopy 27 stents were inserted in 26 patients, mean age: 62 years (range: 37-83), 16 men. Diagnoses were 18 bronchogenic carcinoma, 4 oesophageal carcinoma, 2 metastases, 1 tracheal carcinoma, and 1 schwannoma. The stents were inserted in the following locations: 10 right main bronchus, 8 left main bronchus, 7 trachea, and 2 tracheo-bronchial. There was significant improvement in all functional parameters assessed from before (A), to 1 month (B) and 3 months (C) after stent placement. The measured values (mean +/- SD) were for the WHO scale: A: 2.7 (0.8), B: 1.5 (0.9), C: 1.6 (1.0); for the Karnofsky scale: A: 44 (19), B: 72 (18), C: 71 (21); for the Dyspnoea Index: A: 3.3 (0.7), B: 1.5 (0.8), C: 1.9 (1.2); for FEV(1): A: 1.2 (0.5), B: 1.9 (0.6), C: 1.5 (0.5), and for FVC: A: 2.1 (0.7), B: 2.8 (0.7), C: 2.5 (1.0). Stent-related complications were 4 reversible stent obstructions by secretions, 1 migration. The observation period was mean 4.3 months (range 2 days to 23 months).

CONCLUSION

The studded Polyflex showed excellent efficacy, was very well tolerated, and had a very low migration rate. It presents an improvement over the older smooth model and can be considered a true alternative to the most widely used silastic stent, the Dumon stent.

摘要

背景

Polyflex是一种市售的硅橡胶气道支架,其疗效已得到证实。由于其外表面光滑,在气道壁中的固定较浅,这可能导致支架移位。

目的

研究一种具有带钉外表面的新型Polyflex支架的性能,这种设计应能改善固定效果。

方法

在一项5中心国际研究中,对患有肿瘤性中央气道狭窄且狭窄程度超过正常直径50%的有症状患者前瞻性地测试了这种新型支架。记录了支架置入前、置入后1个月和3个月的置入技术、支架置入效果及与支架相关的并发症。

结果

在全身麻醉和硬质支气管镜检查下,26例患者置入了27枚支架,平均年龄62岁(范围:37 - 83岁),男性16例。诊断包括18例支气管源性癌、4例食管癌、2例转移瘤、1例气管癌和1例神经鞘瘤。支架置入位置如下:右主支气管10例、左主支气管8例、气管7例、气管支气管2例。从支架置入前(A)到置入后1个月(B)和3个月(C),所有评估的功能参数均有显著改善。测量值(均值±标准差)如下:世界卫生组织(WHO)量表:A:2.7(0.8),B:1.5(0.9),C:1.6(1.0);卡诺夫斯基(Karnofsky)量表:A:44(19),B:72(18),C:71(21);呼吸困难指数:A:3.3(0.7),B:1.5(0.8),C:1.9(1.2);第1秒用力呼气容积(FEV₁):A:1.2(0.5),B:1.9(0.6),C:1.5(0.5);用力肺活量(FVC):A:2.1(0.7),B:2.8(0.7),C:2.5(1.0)。与支架相关的并发症包括4例因分泌物导致的可逆性支架阻塞和1例移位。观察期平均为4.3个月(范围:2天至23个月)。

结论

带钉的Polyflex显示出优异的疗效,耐受性良好,移位率很低。与旧的光滑型号相比有改进,可被视为最广泛使用的硅橡胶支架——Dumon支架的真正替代品。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验